Study may explain why prostate tumor cells become resistant to hormone therapy
February 3rd 2005Certain mutations in the androgen receptor protein appear to cause advanced and invasive prostate cancer, at least in a mouse model, according to a recent study in the Proceedings of the National Academy of Sciences (2005; 102:1151-6).
Interferon is safe, effective for Peyronie's disease
February 1st 2005Buenos Aires, Argentina--For men with Peyronie's disease with or without erectile dysfunction, intralesional interferon alfa-2b (Intron-A) may offer a simple, safe, and effective treatment for improving penile curvature and the ability to have sexual intercourse. So say Cleveland Clinic researchers, who presented the results of a study on the drug in this population at the International Society for Sexual and Impotence Research world congress here.
Oral drug effectively improves premature ejaculation
February 1st 2005Buenos Aires, Argentina--The serotonin transport inhibitor dapoxetine appears to be a well-tolerated and effective agent for the treatment of premature ejaculation, according to the results of a phase II study presented at the International Society for Sexual and Impotence Research world congress.
Laparoscopic training methods evolve, improve
February 1st 2005Mumbai, India--Since the introduction of laparoscopic surgery to urology in the early 1990s, academic and community urology programs alike have been striving to learn and advance the specialized skills required to perform laparoscopic urologic surgery. At the 22nd World Congress on Endourology, an extensive session was de-voted to reporting the recent advances made in the field of laparoscopic training.
Alternative therapies weighed for PCa prevention
February 1st 2005Chicago--In the wake of the surprising results of the Prostate Cancer Prevention Trial (PCPT), researchers continue to investigate possible therapies for prostate cancer prevention. Some focus on alternative therapies, with a major effort underway to determine the possible efficacy of selenium and vitamin E in the form of the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Robotic RP technique helps preserve sexual function
February 1st 2005Mumbai, India--Safeguarding sexual function following radical prostatectomy remains a great concern for patients undergoing the procedure. Preservation of the posterior-lateral prostatic neurovascular bundles at the time of surgery is critical for recovery of erectile function. The experience gained with the open radical retro-pubic prostatectomy has allowed urologists performing robotic prostatectomy to utilize an anatomic nerve-sparing approach to maximize the potential for recovery of sexual function.
Reliability is what men want most in ED treatment
February 1st 2005Buenos Aires, Argentina--In a multinational study aimed at pinpointing the attributes men consider desirable in treatments for erectile dysfunction, researchers have found that reliability of treatment ranks first, followed closely by tolerability.
Rethinking the PCPT: New panel convening
February 1st 2005Chicago--A panel of experts is expected to convene to reconsider the controversial findings of the Prostate Cancer Prevention Trial (PCPT), in particular, the indication that finasteride (Proscar) may prevent prostate cancer and yet lead to more severe grades of cancer in those men who develop it.